Skip to main content

Pfizer COVID-19 pill could cut severe illness by 89%, company says

Pfizer Inc. announced Friday that its pill to treat novel COVID-19 was found to reduce the risk of hospitalization or death by 89% among high-risk adult patients in a clinical trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.